Y. Abeling

Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting

G. D'Haens, A. Volkers, K. Gecse, 2023, Diagnostics.